RT Journal Article
SR Electronic
T1 Did the National lockdown lock COVID-19 down in India, and reduce pressure on health infrastructure?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.27.20115329
DO 10.1101/2020.05.27.20115329
A1 Husain, Zakir
A1 Das, Arup Kumar
A1 Ghosh, Saswata
YR 2020
UL http://medrxiv.org/content/early/2020/05/29/2020.05.27.20115329.abstract
AB Background & objectives The spread of COVID-19 in India has posed a major challenge for policy makers. Policy response in form of imposition of a prolonged national lockdown has imposed substantial costs on the entire population. But the extent to which it has contained the spread of the epidemic needs to be assessed.Methods We use an Interrupted Time Series model to assess the success of lockdowns in containing COVID-19. In the second step, we use four variants of the SIR models to develop a counterfactual—what would have happened without the lockdown. These results are compared with actual data. The analysis is undertaken for India, and Maharashtra, Gujarat, Delhi, and Tamil Nadu.Results Lockdown has reduced the number of COVID-19 cases by 23.65 to 337.73 lakh in Class I cities and towns, where COVID has mainly spread. It has averted about 0.01 to 0.10 lakh deaths. At the regional level, however, lockdown has averted a health crisis as existing ICU and ventilator facilities for critically ill patients would have been inadequate.Interpretation & conclusions Overall, the results for three of the four models reveal that lockdown has a modest impact on spread of COVID-19; the health infrastructure at the national level is not over strained, even at the peak. At the regional level, on the other hand, lockdowns may have been justified. However, given that identification of new cases is limited by levels of daily testing that are low even by Asian standards, analysis based upon official data may have limitations and result in flawed decisions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding or sponsorship received by us.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No patient / clinical data was used. SO IRB approval is not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData on which the research is based is available publicly. Sources have been cited in submission. https://www.covid19india.org/